Cyclin H activation and drug susceptibility of the Pfmrk cyclin dependent protein kinase from Plasmodium falciparum

Molecular and Biochemical Parasitology

Volumn 107, Issue 1, 2000, Pages 45-55

  Waters, Norman C ^a   Woodard, Cassandra L ^a   Prigge, Sean T ^a  

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

Author keywords

Cyclin dependent protein kinase; Cyclin H; Drug discovery; Molecular model; Olomoucine; Pfmrk; Plasmodium falciparum

Indexed keywords

CYCLIN DEPENDENT KINASE; CYCLINE; HISTONE H1; OLOMOUCINE; PROTAMINE KINASE; ROSCOVITINE;

ARTICLE; AUTOPHOSPHORYLATION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME PURIFICATION; ENZYME STRUCTURE; MOLECULAR MODEL; NONHUMAN; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM;

AMINO ACID SEQUENCE; ANIMALS; CYCLIN-DEPENDENT KINASES; CYCLINS; ENZYME INHIBITORS; HUMANS; KINETIN; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PLASMODIUM FALCIPARUM; PROTEIN CONFORMATION; PROTEIN KINASES; PROTEIN-SERINE-THREONINE KINASES; PURINES;

ESCHERICHIA COLI; EUKARYOTA; PLASMODIUM FALCIPARUM; PROTOZOA;

EID: 0034654447     PISSN: 01666851     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-6851(99)00229-7     Document Type: Article

References (43)

1. Morgan D.O. Cyclin-dependent kinases: engines, clocks, and microprocessors. Annu. Rev. Cell. Dev. Biol. 13:1997;261-291.
2. CDC2. Cell. 63:1990;1013-1024.
3. Marcote M.J., Knighton D.R., Basi G., Sowadski J.M., Brambilla P., Draetta G., Taylor S.S. A three-dimensional model of the cdc2 protein kinase: localization of cyclin and suc1 binding regions and phosphorylation sites. Mol. Cell. Biol. 13:1993;5122-5131.
4. Morgan D.O. Principles of CDK regulation. Nature. 374:1995;131-134.
5. Jeffrey P.D., Russo A.A., Polyak K., Gibbs E., Hurwitz J., Massague J., Pavletich N.P. Mechanism of CDK activation revealed by the structure of a cyclin A-CDK2 complex. Nature. 376:1995;313-320.
6. Willems A.R., Lanker S., Patton E.E., Craig K.L., Nason T.F., Mathias N., Kobayashi R., Wittenberg C., Tyers M. Cdc53 targets phosphorylated G1 cyclins for degradation by the ubiquitin proteolytic pathway. Cell. 86:1996;453-463.
7. Sherr C.J., Roberts J.M. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev. 9:1995;1149-1163.
8. Hunter T., Pines J. Cyclins and cancer II: cyclin D and CDK inhibitors come of age. Cell. 79:1994;573-582.
9. Ross-Macdonald P.B., Graeser R., Kappes B., Franklin R., Williamson D.H. Isolation and expression of a gene specifying a cdc2-like protein kinase from the human malaria parasite Plasmodium falciparum. Eur. J. Biochem. 220:1994;693-701.
10. Li J.L., Robson K.J.H., Chen J.L., Targett G.A.T., Baker D.A. Pfmrk, a MO15-related protein kinase from Plasmodium falciparum. Gene cloning, sequence, stage-specific expression and chromosome localization. Eur. J. Biochem. 241:1996;805-813.
11. Doerig C., Doerig C., Horrocks P., Coyle J., Carlton J., Sultan A., Arnot D., Carter R. Pfcrk-1, a developmentally regulated cdc2-related protein kinase of Plasmodium falciparum. Mol. Biochem. Parasitol. 70:1995;167-174.
12. Vinkenoog R., Speranca M.A., Ramesar J., Thomas A.W., Del Portillo H.A., Janse C.J., Waters A.P. Characterization of the cdc2-related kinase 2 gene from Plasmodium knowlesi and P. berghei. Mol. Biochem. Parasitol. 95:1998;229-240.
13. Graeser R., Franklin R.M., Kappes B. Mechanisms of activation of the cdc2-related kinase PfPK5 from Plasmodium falciparum. Mol. Biochem. Parasitol. 79:1996;125-127.
14. Graeser R., Wernli B., Franklin R.M., Kappes B. Plasmodium falciparum protein kinase 5 and the malarial nuclear division cycles. Mol. Biochem. Parasitol. 82:1996;37-49.
15. Arnot D.E., Gull K. The Plasmodium cell-cycle: facts and questions. Ann. Trop. Med. Parasitol. 92:1998;361-365.
16. Kinnaird J.H., Mottram J.C. Plasmodium cdc2-related kinases: do they regulate stage differentiation. Parasitol. Today. 13:1997;7-8.
17. Leete T.H., Rubin H. Malaria and the cell cycle. Parasitol. Today. 12:1996;442-444.
18. CDC2. EMBO J. 12:1993;3123-3132.
19. Fesquet D., Labbe J.C., Derencourt J., Capony J.P., Galas S., Girard F., Lorca T., Shuttleworth J., Doree M., Cavadore J.C. The MO15 gene encodes the catalytic subunit of a protein kinase that activates cdc2 and other cyclin-dependent kinases (CDKs) through phosphorylation of Thr161 and its homologues. EMBO J. 12:1993;3111-3121.
20. Fisher R.P., Morgan D.O. A novel cyclin associates with MO15/CDK7 to form the CDK-activating kinase. Cell. 78:1994;713-724.
21. Roy R., Adamcsewski J.P., Seroz T., Vermeulen W., Tassan J.P., Schaeffer L., Nigg E.A., Hoeijmaker J.H.J., Egly J.M. The MO15 cell cycle kinase is associated with the TFIIH transcription-DNA repair factor. Cell. 79:1994;1093-1101.
22. Serizawa H., Makela T.P., Conaway J.W., Conaway R.C., Weinberg R.A., Young R.A. Association of CDK-activating kinase subunits with transcription factor TFIIH. Nature. 374:1995;280-282.
23. Shiekhatter R., Mermelstein F., Fisher R.P., Drapkin R., Dynlacht B., Wessling H.C., Morgan D.O., Reinberg D. CDK-activating kinase complex is a component of human transcription factor TFIIH. Nature. 374:1995;283-287.
24. Del Tito B.J., Ward J.M., Hodgson J., Gershater C.J., Edwards H., Wysocki L.A., Watson F.A., Sathe G., Kane J.F. Effects of a minor isoleucyl tRNA on heterologous protein translation in Escherichia coli. J. Bacteriol. 177:1995;7086-7091.
25. Saul A., Battistutta D. Codon usage in Plasmodium falciparum. Mol. Biochem. Parasitol. 27:1998;35-42.
26. Schulze-Gahmen U., Brandsen J., Jones H.D., Morgan D.O., Meijer L., Vesely J., Kim S.H. Multiple modes of ligand recognition: crystal structures of cyclin-dependent protein kinase 2 in complex with ATP and two inhibitors, olomoucine and isopentenyladenine. Proteins. 22:1995;378-391.
27. Evans S.V. SETOR: hardware-lighted three-dimensional solid model representations of macromolecules. J. Mol. Graph. 11:1993;134-138.
28. Peeper D.S., Parker L.L., Ewen M.E., Toebes M., Hall F.L., Xu M., Zantema A., Van der Eb A.J., Piwnica-Worms H. A- and B-type cyclins differentially modulate substrate specificity of cyclin-CDK complexes. EMBO J. 12:1993;1947-1954.
29. Diehl J.A., Sherr C.J. A dominate-negative cyclin D1 mutant prevents nuclear import of cyclin-dependent kinase 4 (CDK4) and its phosphorylation by CDK-activating kinase. Mol. Cell. Biol. 17:1997;7362-7374.
30. Vesely J., Havlicek L., Strnad M., Blow J.J., Donella-Deanna A., Pinna L., Letham D.S., Kato J.Y., Detivaud L., Leclerc S., Meijer L. Inhibition of cyclin-dependent kinases by purine analogues. Eur. J. Biochem. 224:1994;771-786.
31. Meijer L., Borgne A., Mulner O., Chong J.P.J., Blow J.J., Inagaki N., Inagaki M., Delcros J.G., Moulinoux J.P. Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2, and cdk5. Eur. J. Biochem. 243:1997;527-536.
32. Gomez E.B., Kornblihtt A.R., Tellez-Inon M.T. Cloning of a cdc2-related protein kinase from Trypanosoma cruzi that interacts with mammalian cyclins. Mol. Biochem. Parasitol. 91:1998;337-351.
33. Lee M.G., Nurse P. Complementation used to clone a human homologue of the fission yeast cell cycle control gene cdc2. Nature. 327:1987;31-35.
34. Umeda M., Bhalerao R.P., Schell J., Uchimiya H., Koncz C. A distinct cyclin-dependent kinase activating kinase of Arabidopsis thaliana. Proc. Natl. Acad. Sci. USA. 95:1998;5021-5026.
35. Wastling J.M., Kinnaird J.H. Isolation and characterization of a genomic clone encoding a cdc2-related kinase of Toxoplasma gondii. Mol. Biochem. Parasitol. 94:1998;143-148.
36. Mottram J.C., Smith G. A family of trypanosome cdc2-related protein kinases. Gene. 162:1995;833-839.
37. Mottram J.C., Kinnard J., Shiels B.R., Tait A., Barry J.D. A novel CDC2-related protein kinase from Leishmania mexicana, LmmCRK1, is post-translationally regulated during the life cycle. J. Biol. Chem. 268:1993;21044-21051.
38. Wang Y., Dimitrov K., Garrity L.K., Sazer S., Beverly S.M. Stage-specific activity of the Leishmania major CRK3 kinase and functional rescue of a Schizosaccharomyces pombe cdc2 mutant. Mol. Biochem. Parasitol. 96:1998;139-150.
39. Kim K.K., Chamberlin H.M., Morgan D.O., Kim S.H. Three-dimensional structure of human cyclin H, a positive regulator of the CDK-activating kinase. Nat. Struct. Biol. 3:1996;849-855.
40. MO15 associates with a p36 subunit and requires both nuclear translocation and Thr176 phosphorylation to generate cdk-activating kinase activity in Xenopus oocytes. EMBO J. 13:1994;5155-5164.
41. Fisher R.P., Jin P., Chamberlin H.M., Morgan D.O. Alternative mechanisms of CAK assembly require an assembly factor or an activating kinase. Cell. 83:1995;47-57.
42. Martinez A.M., Afshar M., Martin F., Cavadore J.C., Labbe J.C., Doree M. Dual phosphorylation of the T-loop in cdk7: its role in controlling cyclin H binding and CAK activity. EMBO J. 16:1997;343-354.
43. Meijer L. Chemical inhibitors of cyclin-dependent kinases. Trends Cell Biol. 6:1996;393-397.